Vasopharm picks up funding
Vasopharm GmbH, a German developer of treatments for traumatic brain injury, has secured 9.5 million euros in financing. HeidelbergCapital Private Equity and EF Investments led the round.
11 July 2019•1 min read
Vasopharm GmbH, a German developer of treatments for traumatic brain injury, has secured 9.5 million euros in financing. HeidelbergCapital Private Equity and EF Investments led the round.
